Interleukin-2 therapy and CD4+ T cells in HIV-1 infection.
Vento
Sandro
S
Section of Infectious Diseases, Department of Pathology, University of Verona, 37138 Verona, Italy. ventosandro@yahoo.it
Cainelli
Francesca
F
Temesgen
Zelalem
Z
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D018791:CD4 Lymphocyte Count; D004334:Drug Administration Schedule; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology; D015497:HIV-1; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D007376:Interleukin-2